Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HV.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.405EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.405ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.405ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.405EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.405EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.405ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.282EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.282ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.282ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.282EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.282EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.282ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.228EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18757.2South Korea
B.1.1.228EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.228ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.228ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.228EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.228EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.228ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.228ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.523EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.523ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.523ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.523EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.523EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.523ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.36.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.36.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.36.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.418ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.418ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used